Company patents

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. demonstrates a clear and intensifying focus on Medical Diagnostics & Surgery, which constitutes 76.4% of its portfolio and saw a remarkable 1100.0% growth in 2024, followed by a 50.0% increase in 2025, despite a partial decline of 38.9% so far in 2026. Surprisingly, the company also maintains a significant presence in Drug Delivery Devices (45.5% of portfolio), showing consistent patenting activity with 7 patents in both 2025 and so far in 2026, suggesting a dual-pronged strategy in medical device innovation.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

55 US filings (since 2023) · 4 categories · 3 themes

Patents

Showing 1-10 of 78

Page 1 of 8